Manufacture of a Vaccine Targeting Frame-Shift Mutations Characteristic of Tumors with Microsatellite Instability

针对微卫星不稳定性肿瘤移码突变特征的疫苗的制备

• 批准号: 10019070
• 负责人: Beth Tebeau
• 金额: $ 147万
• 依托单位: ADVANCED BIOSCIENCE LABORATORIES, INC.
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-19 至 2020-07-18
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10019070
• 关键词: Address; Adjuvant; Annual Reports; Back; Characteristics; Chemistry; Clinical Trials; Contractor; Cyclic GMP; Data; Documentation; Frameshift Mutation; Freeze Drying; Guidelines; Health; Injections; International; Investigational Drugs; Investigational New Drug Application; Marketing; Methods; Microsatellite Instability; Peptides; Performance; Pharmaceutical Preparations; Phase; Preparation; Records; Reporting; Schedule; Services; Sterility; Testing; Toxicology; Vaccines; Vial device; Water; Work; analytical method; authority; base; drug testing; meetings; novel therapeutics; reconstitution; repository; research and development; research clinical testing; response; stability testing; symposium; tumor

The purpose of this task order is to acquire research & development services in support of the project, “Manufacture of a Vaccine Targeting Frame-Shift Mutations Characteristic of Tumors with Microsatellite Instability”, through the tasks identified in the Statement of Work dated 5/20/2019.

该任务令的目的是通过2019年5月20日工作说明中确定的任务，获得研发服务，以支持“制造针对具有微卫星不稳定性的肿瘤的帧移突变特征的疫苗”项目。